SUMMIT RISE Study of Acute Ischemic Stroke Patients

Phase 4RecruitingNCT07436156

Route 92 Medical, Inc.500 enrolled

Overview

SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

500

Conditions

Acute Ischemic Stroke

Interventions

Route 92 Medical Reperfusion SystemsDEVICE

Mechanical thrombectomy with the Route 92 Medical Reperfusion Systems

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System * Informed consent completed and documented within 72 hours following thrombectomy procedure * Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well * Age ≥ 18 years Exclusion Criteria: * None

Locations (1)

Route 92 Medical, Inc.

West Jordan, Utah, United States

RECRUITING

Outcomes

Primary Outcomes

Periprocedural eTICI measurement of revascularization

Revascularization status checklist

Time frame: Periprocedural

Central Contacts

Renee Kochevar Vice President, Clinical Research, PhD, ALM

CONTACT

650-581-1179 reneek@r92m.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.